Resource Logo
CDC HIV/AIDS/Viral Hepatitis/STD/TB Prevention News Update

Activist Wins a MacArthur


Village Voice (06/24/97) Vol 42, No. 25, P. 26

The John D. and Catherine T. MacArthur foundation recently awarded AIDS activist Mark Harrington, founder of the Treatment Action Group, a $240,000 fellowship for his campaign to restructure AIDS research at the National Institutes of Health. Harrington has been involved in AIDS activism for nine years, ever since a good friend became ill with the disease. In 1989, he led a successful protest that led to a repeal of the Food and Drug Administration's shutting off a supply of drugs to treat AIDS-related blindness. One year later, Harrington found out he was HIV-positive, after his friend died and an ex-lover was diagnosed with AIDS. Harrington says he is now trying to determine "how this [award] money can be used to seed more work."


Copyright © 1997 -CDC Prevention News Update, Publisher. All rights reserved to Information, Inc., Bethesda, MD. The CDC National Center for HIV, STD and TB Prevention provides the following information as a public service only. Providing synopses of key scientific articles and lay media reports on HIV/AIDS, other sexually transmitted diseases and tuberculosis does not constitute CDC endorsement. This daily update also includes information from CDC and other government agencies, such as background on Morbidity and Mortality Weekly Report (MMWR) articles, fact sheets, press releases and announcements. Reproduction of this text is encouraged; however, copies may not be sold, and the CDC HIV/STD/TB Prevention News Update should be cited as the source of the information. Contact the sources of the articles abstracted below for full texts of the articles.

Information in this article was accurate in July 7, 1997. The state of the art may have changed since the publication date. This material is designed to support, not replace, the relationship that exists between you and your doctor. Always discuss treatment options with a doctor who specializes in treating HIV.